1. Home
  2. HRMY vs USA Comparison

HRMY vs USA Comparison

Compare HRMY & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.82

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

USA

Liberty All-Star Equity Fund

HOLD

Current Price

$6.30

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
USA
Founded
2017
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HRMY
USA
Price
$37.82
$6.30
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$51.33
N/A
AVG Volume (30 Days)
695.1K
880.5K
Earning Date
11-04-2025
01-01-0001
Dividend Yield
N/A
9.66%
EPS Growth
50.44
N/A
EPS
3.17
N/A
Revenue
$825,944,000.00
N/A
Revenue This Year
$23.11
N/A
Revenue Next Year
$16.15
N/A
P/E Ratio
$12.04
N/A
Revenue Growth
21.13
N/A
52 Week Low
$25.52
$5.62
52 Week High
$40.93
$7.09

Technical Indicators

Market Signals
Indicator
HRMY
USA
Relative Strength Index (RSI) 54.65 58.53
Support Level $37.12 $6.11
Resistance Level $39.60 $6.35
Average True Range (ATR) 1.15 0.06
MACD -0.38 0.02
Stochastic Oscillator 17.33 77.08

Price Performance

Historical Comparison
HRMY
USA

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

Share on Social Networks: